to examine the natural history of long-term anti-arrhythmic therapy in patients with benign and potentially lethal ventricular premature complexes ( vpcs ) , 28 patients with initial efficacy with moricizine ( greater than 75 % suppression of baseline mean vpcs/hr and greater than 90 % suppression of repetitive vpcs ) were prospectively followed for 1 to 56 ( mean +/- standard deviation 25 +/- 17 ) months .
C0003195
anti-arrhythmic
C0079856
moricizine